Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$997K Buy
2,510
+480
+24% +$137K ﹤0.01% 1415
2026
Q1
$360K Sell
2,030
-1,668
-45% -$342K ﹤0.01% 1871
2025
Q4
$947K Sell
3,698
-1,357
-27% -$356K 0.01% 1250
2025
Q3
$1.01M Sell
5,055
-811
-14% -$213K 0.01% 1079
2025
Q2
$1.43M Buy
5,866
+1,268
+28% +$316K 0.01% 813
2025
Q1
$1.22M Buy
4,598
+999
+28% +$270K 0.01% 744
2024
Q4
$939K Buy
3,599
+823
+30% +$221K 0.01% 791
2024
Q3
$879K Buy
2,776
+1,760
+173% +$627K 0.02% 616
2024
Q2
$380K Buy
+1,016
New +$343K 0.02% 634

Other funds holding HUM

&Partners's HUM Position: Q2 2026 in Review

&Partners increased its Humana (HUM) stake by 24% in Q2 2026, buying an estimated $137K and bringing the position to 2,510 shares worth $997K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

&Partners first reported a position in HUM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.43M in Q2 2025. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • &Partners held 2,510 shares of Humana worth $997K as of Q2 2026.
  • &Partners bought 480 Humana shares in Q2 2026, an estimated $137K.
  • Humana made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1415 holding.
  • &Partners first reported a position in Humana in Q2 2024 and has held it in 9 quarters since.
  • &Partners's Humana position peaked at $1.43M in Q2 2025.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.